This was further supported by the lack of FBLN2 expression in the stromal regions of tumours where the metastatic stromal markers TN-C, POSTN, and GAGs26,47,48 were all expressed, as well as FBLN2′s presence around normal ducts where these metastatic markers were absent. This evidence concerns the gene POSTN and neoplasm.